BioSintNA incluirá en su formulación acciones de promoción y visibilidad, formación y talento, fomento y desarrollo del tejido empresarial, regulación y ética, sostenibilidad del modelo de negoc...
Medibiofarma, empresa biofarmacéutica navarra que se dedica a descubrir y desarrollar nuevas terapias para enfermedades de alta necesidad médica, ha cerrado una ronda de financiación por valor de u...
The investment will be used to complete three phase II clinical trials in which the efficacy of its most advanced products is being studied, namely PBF-680 in patients with chronic obstructive pulmona...
Carles Domènech, Executive Chairman, Chief Scientific Officer and Co-Founder of AbilityPharma, said: "We are very happy to have reached this agreement with SciClone. This investment represents a cont...
The biopharmaceutical company Ability Pharmaceuticals SL announced today that it has been awarded €5 million blended financing from the Horizon Europe, European Innovation Council (EIC) Accelerator ...
La compañía ha conseguido 2 millones de euros de Sodena, Inveready y el Ministerio de Economía y Competitividad. La compañía se dedica a la innovación nanotecnológica dirigida al desarrollo de ...